Search Results - "Duroni, Valeria"

Alterations in Plasma Lipid Profiles Associated with Melanoma and Therapy Resistance by Dei Cas, Michele, Ciniselli, Chiara Maura, Vergani, Elisabetta, Ciusani, Emilio, Aloisi, Mariachiara, Duroni, Valeria, Verderio, Paolo, Ghidoni, Riccardo, Paroni, Rita, Perego, Paola, Beretta, Giovanni Luca, Gatti, Laura, Rodolfo, Monica

“…Dysfunctions of lipid metabolism are associated with tumor progression and treatment resistance of cutaneous melanoma. BRAF/MEK inhibitor resistance is linked…”
Get full text

A gene expression-based classifier for HER2-low breast cancer by Di Cosimo, Serena, Pizzamiglio, Sara, Ciniselli, Chiara Maura, Duroni, Valeria, Cappelletti, Vera, De Cecco, Loris, De Marco, Cinzia, Silvestri, Marco, De Santis, Maria Carmen, Vingiani, Andrea, Paolini, Biagio, Orlandi, Rosaria, Iorio, Marilena Valeria, Pruneri, Giancarlo, Verderio, Paolo

“…In clinical trials evaluating antibody-conjugated drugs (ADCs), HER2-low breast cancer is defined through protein immunohistochemistry scoring (IHC) 1+ or 2+…”
Get full text

Quality of life after prophylactic surgery for colorectal adenomatous polyposis by Rausa, Emanuele, Ciniselli, Chiara Maura, Signoroni, Stefano, Boer, Laura Sophie, Oldhoff, Loïs, Dijk, Laura, Van Luijk, Franka, Ricci, Maria Teresa, Ghidoli, Chiara, Duroni, Valeria, Brignola, Clorinda, Borreani, Claudia, Alfieri, Sara, Apolone, Giovanni, Verderio, Paolo, Vitellaro, Marco

“…Purpose Colorectal adenomatous polyposis is characterized by the onset of tens to thousands of adenomas in the colorectal epithelium and, if not treated, leads…”
Get full text

Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast by Ciniselli, Chiara M., Verderio, Paolo, Baili, Paolo, Sant, Milena, Pizzamiglio, Sara, Duroni, Valeria, de Braud, Filippo G., Folli, Secondo, Scaperrotta, Gianfranco, De Santis, Maria C., Apolone, Giovanni, De Marco, Cinzia, Vingiani, Andrea, Cappelletti, Vera, Pruneri, Giancarlo, Di Cosimo, Serena

“…Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer, with 5-10% of cases progressing into invasive disease. Herein, we…”
Get full text

Abstract PO4-14-08: A gene expression-based classifier for HER2-low breast cancer by Cosimo, Serena Di, Pizzamiglio, Sara, Ciniselli, Chiara Maura, Duroni, Valeria, Cappelletti, Vera, de Cecco, Loris, De Santis, Maria Carmen, Orlandi, Rosaria, Iorio, Marilena, Silvestri, Marco, Pruneri, Giancarlo, Verderio, Paolo

“…Abstract Background: The definition of HER2-low breast cancer from clinical trials of antibody-conjugated drugs (ADCs) relies on immunohistochemistry scoring…”
Get full text

Abstract 5506: Circulating immature neutrophils early detect hyperprogressive disease upon first-line PD-1/PD-L1 inhibitors in non-small cell lung cancer patients selecting best candidates for platinum-based chemotherapy and PD-1/PD-L1 inhibitors combinations by Ferrara, Roberto, Russo, Giuseppe Lo, Ciniselli, Chiara Maura, Piva, Annamaria, Bassani, Barbara, Jachetti, Elena, Calareso, Giuseppina, Duroni, Valeria, Gregorio, Settimio Di, Proto, Claudia, Prelaj, Arsela, De Toma, Alessandro, Occhipinti, Mario, Brambilla, Marta, Manglaviti, Sara, Mazzeo, Laura, Rinaldi, Arturo, Beninato, Teresa, Ganzinelli, Monica, De Braud, Filippo, Garassino, Marina Chiara, Verderio, Paolo, Colombo, Mario Paolo, Sangaletti, Sabina

“…Abstract Background: Hyperprogressive disease (HPD) has been described in ≃14-25% of pretreated non-small cell lung cancer (NSCLC) patients upon single-agent…”
Get full text

revocación de mandato de 2022 en México: retos en el caso del estado de Guanajuato by Rivera Durón, Nancy Valeria, Cobilt Cruz, Elizabeth Cristina

“…En el año 2022, se llevó a cabo la primera consulta de revocación de mandato (RM) presidencial en México. Hasta el momento, los análisis sobre este proceso no…”
Get full text